← Back to Search

Polyphenol

Resveratrol for Gestational Diabetes

Phase 4
Waitlist Available
Led By Shayne P Taback, MD
Research Sponsored by University of Manitoba
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up recruitment rates will be followed throughout the recruitment phase, which is expected to take 2 years maximum
Awards & highlights

Study Summary

The purpose of this study is to determine if resveratrol supplementation preserves beta cell function and insulin sensitivity in post-partum women following a first diagnosis of gestational diabetes. We hypothesize that daily supplementation with resveratrol will preserve beta cell function and insulin sensitivity.

Eligible Conditions
  • Gestational Diabetes

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~recruitment rates will be followed throughout the recruitment phase, which is expected to take 2 years maximum
This trial's timeline: 3 weeks for screening, Varies for treatment, and recruitment rates will be followed throughout the recruitment phase, which is expected to take 2 years maximum for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in beta cell function
Secondary outcome measures
Change in insulin sensitivity
recruitment rates
treatment adherence
Other outcome measures
change in C-reactive protein
change in glycated hemoglobin
change in liver function
+2 more

Side effects data

From 2013 Phase 2 trial • 24 Patients • NCT02114892
25%
Headache
8%
Abdominal pain
8%
Sickness
100%
80%
60%
40%
20%
0%
Study treatment Arm
Resveratrol
Placebo

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: ResveratrolExperimental Treatment1 Intervention
Resveratrol capsules, 250 mg twice a day for 3 months
Group II: PlaceboPlacebo Group1 Intervention
Corn starch capsules, 1 capsule twice a day for 3 months
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Resveratrol
2014
Completed Phase 3
~730

Find a Location

Who is running the clinical trial?

University of ManitobaLead Sponsor
595 Previous Clinical Trials
199,369 Total Patients Enrolled
Manitoba Institute of Child HealthIndustry Sponsor
8 Previous Clinical Trials
6,816 Total Patients Enrolled
Shayne P Taback, MDPrincipal InvestigatorUniversity of Manitoba

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Can Resveratrol Improve Insulin Sensitivity and Preserve Beta Cell Function Following Gestational Diabetes?
2014. "Can Resveratrol Improve Insulin Sensitivity and Preserve Beta Cell Function Following Gestational Diabetes?". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT01997762.
All > Gestational Diabetes > Diabetes
~10 spots leftby May 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top